Early Relapse after Autologous Hematopoietic Cell Transplantation remains a Poor Prognostic Factor in Multiple Myeloma but Outcomes Have Improved Over Time

Duration of initial disease response remains a strong prognostic factor in multiple myeloma (MM) particularly for upfront autologous hematopoietic cell transplant (AHCT) recipients. We hypothesized that new drug classes and combinations employed prior to AHCT as well as after post-AHCT relapse may h...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Leukemia
Main Authors: Kumar, Shaji K, Dispenzieri, Angela, Fraser, Raphael, Mingwei, Fei, Akpek, Gorgun, Cornell, Robert, Kharfan-Dabaja, Mohamed, Freytes, Cesar, Hashmi, Shahrukh, Hildebrandt, Gerhard, Holmberg, Leona, Kyle, Robert, Lazarus, Hillard, Lee, Cindy, Mikhael, Joseph, Nishihori, Taiga, Tay, Jason, Usmani, Saad, Vesole, David, Vij, Ravi, Wirk, Baldeep, Krishnan, Amrita, Gasparetto, Cristina, Mark, Tomer, Nieto, Yago, Hari, Parameswaran, D’Souza, Anita
פורמט: Artigo
שפה:Inglês
יצא לאור: 2017
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5871538/
https://ncbi.nlm.nih.gov/pubmed/29263438
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2017.331
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים